MIAMI, July 09, 2025 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard Prime carotid stent system for the prevention of stroke, today announced the official commercial launch of the CGuard Prime carotid stent system in the U.S., following its premarket application (PMA) approval from the U.S. Food and Drug Administration (FDA). The CGuard Prime was engineered specifically to minimize both early and late embolism risk by effectively trapping potential emboli against the arterial wal ...

Group 1: Land Resources in Jiangsu Province - Jiangsu Province covers an area of 107,200 square kilometers, accounting for 1.12% of the national land area, primarily consisting of fertile plains suitable for agricultural development [1] Group 2: Soil Pollution Monitoring and Status - In 2023, Jiangsu conducted soil quality monitoring at 778 national monitoring sites, with 94.7% of points showing pollutant levels below risk screening values, indicating overall good soil quality, although construction land pollution remains a concern [2][4] - The province has 87 contaminated sites pending control or remediation as of May 2025, with 57 sites successfully removed from the pollution risk management and remediation list since 2020 [8] Group 3: Fertilizer Usage Trends - Jiangsu has seen a continuous decline in fertilizer usage since 2010, with 2023 usage at 2.6704 million tons, projected to decrease to 2.6126 million tons in 2024 [7] Group 4: Soil Pollution Prevention Funding - The budget for soil pollution prevention in Jiangsu for 2025 is set at 13.839 million yuan, following a peak funding of nearly 200 million yuan in 2022 [11] Group 5: Environmental Safety Goals - The Jiangsu government aims for a 93% safety utilization rate of contaminated farmland by 2025, with a focus on both agricultural and construction land soil safety [12][15]

Public Health & Safety - Ticks are flourishing in many parts of the U S [1] - The report provides information on what actions individuals can take regarding ticks [1]

In 2012, the New York Times published an incredibly powerful story about how a father angrily walked into a Target store holding a handful of coupons for pregnancy related items like baby clothes and cribs in maternity wear. He demanded to speak with the manager and yelled at the manager. My daughter got these coupons in the mail.She's just in high school. Are you encouraging her to become pregnant at this age. The store manager was obviously confused, having no idea what the father was talking about, but h ...

Core Viewpoint - Gilead Sciences, Inc. (GILD) has demonstrated strong stock performance, gaining 27.2% over the past six months, significantly outperforming the industry and broader market indices [1][7]. Gilead's HIV Portfolio - The recent FDA approval of lenacapavir, branded as Yeztugo, introduces the first and only twice-yearly injectable option for HIV prevention in the U.S., enhancing Gilead's market-leading HIV treatment portfolio [2][4]. - Gilead's flagship drug, Biktarvy, holds over 51% market share in the U.S. treatment market, while Descovy maintains over 40% market share in the PrEP market [3][4]. - Yeztugo addresses barriers to PrEP adoption, such as adherence and healthcare access, and is expected to increase uptake among underserved populations [5][4]. Financial Performance and Growth - Gilead's stock has outperformed the industry, sector, and S&P 500 index, supported by the FDA approval of Yeztugo and rising earnings estimates [6][7]. - Earnings estimates for Gilead have increased, with the 2025 bottom-line estimate rising to $7.92 from $7.91, and the 2026 estimate improving to $8.48 from $8.39 [15]. Liver Disease Portfolio - Gilead's liver disease portfolio has been strengthened by the FDA approval of seladelpar for primary biliary cholangitis (PBC), which has shown encouraging initial uptake [9][10]. Oncology Business Challenges - Gilead's oncology portfolio faces challenges, particularly in the Cell Therapy franchise due to competitive pressures, but positive results from the ASCENT-03 study on Trodelvy may bolster future growth [11][12]. Strategic Positioning - Gilead's strategic collaborations and acquisitions, including a partnership with Merck for HIV treatment, position the company for continued growth despite competitive pressures from other firms like GSK [17][18]. - The company maintains a strong cash position of $7.9 billion, supporting its attractive dividend yield of 2.83%, which is sustainable [19].

way. NBC News correspondent Jay Gray joins us now from Kurville, Texas, where dozens are still missing. Jay, good morning. Joe Savannah, good morning to you.And speaking to the search, the rescue, the recovery, it is still going on around the clock. Hundreds of first responders, including those in the air. We've seen before sunrise here multiple choppers scanning this area.We want to give you a firsthand look as well at some of the devastation the flood waters left behind. The family inside this home escape ...

yehi guess 'TGE' in this case could also be calledThe Great Extractiongoodalexander (@goodalexander):Pump Fun be like “okay 2 quarters of back to back -25% sequential growth and our average user is insolvent/ on summer break let’s do a high FDV token sale and max extract” ...

PHILADELPHIA, July 7, 2025 /PRNewswire/ -- The Board of Directors of FS Credit Opportunities Corp. (the Fund) (NYSE: FSCO) announced the monthly distribution for July 2025. The distribution of $0.0678 per share will be paid on July 31, 2025. Further information on the distribution is summarized in the charts below.The current annualized distribution rate equates to an annualized distribution yield1 of 11.1% and 11.2%, respectively, based on the Fund's net asset value (NAV) and market price as of June 30, 20 ...

Core Viewpoint - The Jiangsu grassroots football league is experiencing a surge in popularity, with record attendance and significant commercial growth, highlighting the cultural significance of football in the region [1][2][3]. Group 1: Attendance and Engagement - The match between Nanjing and Suzhou teams on July 5 attracted 60,396 spectators, setting a new record for amateur football events in China, just 5,000 short of the highest attendance in Chinese Super League history [1]. - The enthusiasm for the league is evident, with over 200,000 tickets sold within 10 seconds for the "Jiangsu Derby" match, showcasing the high demand for local football [1]. Group 2: Innovative Measures and Sponsorship - To ensure smooth operations during high temperatures, innovative cooling technologies were implemented, including fog cannons and industrial ice blocks, effectively lowering the perceived temperature by over 5 degrees [2]. - The league has seen a dramatic increase in sponsorship, growing from 6 sponsors at its inception to nearly 30, including major brands like Heineken and JD.com, indicating a significant rise in commercial value [2]. Group 3: Cultural Impact and Community Involvement - The league has fostered a strong cultural identity in Jiangsu, with 95.2% of residents aware of the league, and nearly 80% being non-traditional fans, including homemakers and retirees [3]. - The ongoing success of the league is enhancing regional cultural recognition and economic circulation, serving as a model for similar cultural and sports initiatives in other regions [3].

Group 1 - The article promotes a premium service called "Value in Corporate Events" that focuses on major earnings events, M&A, IPOs, and other significant corporate events with actionable investment ideas [1] - The service aims to provide members with opportunities to capitalize on various corporate events, covering 10 major events a month to identify the best investment opportunities [1] Group 2 - The article includes a disclosure stating that the author has no stock or derivative positions in any mentioned companies and does not plan to initiate any positions within the next 72 hours [2] - It emphasizes that past performance is not indicative of future results and that no specific investment recommendations are provided [2]